News
GlaxoSmithKline to spend $100M expanding Hamilton, Montana facility
April 24, 2019 /
Drugmaker GlaxoSmithKline has announced $100 million of new investment in its manufacturing site in Montana.
British-based GSK said in a statement released Wednesday that it will expand the production capacity at its Hamilton facility, where it produces components used in several of vaccines, including ones to help prevent malaria and shingles.
MATR Supporters (view all)
Posted in: Montana Business, Montana Economic Development
Sorry, we couldn't find any posts. Please try a different search.